Page 6 - Chief Commercialization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Greetings and welcome to the TG Therapeutics Fourth Quarter and Year-End 2020 Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] I would now like to turn the conference over to your host, Jenna Bosco, Senior Vice President of Corporate Communications. Please go ahead. Jenna Bosco -- Senior Vice President of Corporate Communications Thank you. Welcome everyone, and thanks for joining us this morning. I'm Jenna Bosco and with me today to discuss the fourth quarter and year-end 2020 financial results and p...

Scott Huennekens joins 270Surgical Board of Directors, Observer and Advisor USA - English Share this article Share this article NETANYA, Israel and DALLAS, Jan. 26, 2021 /PRNewswire/ -- 270Surgical Ltd is pleased to announce that Scott Huennekens has joined the Board of Directors team as an Observer and will also act as an advisor to the Board and CEO effective immediately. Scott has over 25 years of experience in the medical device, technology, and diagnostics sectors as an entrepreneur, CEO, investor, and board member. He has served in these capacities across 10 plus companies, ranging fro...

Share: Pelvital, a privately held medical device company that has developed Flyte™, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence, announced today that Ryan Willemsen has been appointed Chief Commercialization Officer. In this role, Willemsen will be responsible for leading market adoption of Flyte, building a global sales and distribution capability, establishing operational infrastructure to scale the growth of Pelvital, and helping to assure the financial wellbeing of the company. With more than 14 years of medical technology leadership e...

Pelvital Appoints Chief Commercial Officer MINNEAPOLIS–(BUSINESS WIRE)–Pelvital, a privately held medical device company that has developed Flyte™, a clinically proven, FDA-cleared, non-surgical treatment for female stress urinary incontinence, announced today that Ryan Willemsen has been appointed Chief Commercialization Officer. In this role, Willemsen will be responsible for leading market adoption of Flyte, building a global sales and distribution capability, establishing operational infrastructure to scale the growth of Pelvital, and helping to assure the financial wellbeing of the...